These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23619104)

  • 1. Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
    Gleeson M; Meiser B; Barlow-Stewart K; Trainer AH; Tucker K; Watts KJ; Friedlander M; Kasparian N
    Oncol Nurs Forum; 2013 May; 40(3):275-83. PubMed ID: 23619104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
    Meiser B; Gleeson M; Watts K; Peate M; Zilliacus E; Barlow-Stewart K; Saunders C; Mitchell G; Kirk J
    Oncol Nurs Forum; 2012 Mar; 39(2):E101-11. PubMed ID: 22374498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
    Meiser B; Gleeson M; Kasparian N; Barlow-Stewart K; Ryan M; Watts K; Menon D; Mitchell G; Tucker K
    Gynecol Oncol; 2012 Jan; 124(1):153-7. PubMed ID: 22032838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer survivors: qualitative analysis of the symptom of sexuality.
    Wilmoth MC; Hatmaker-Flanigan E; LaLoggia V; Nixon T
    Oncol Nurs Forum; 2011 Nov; 38(6):699-708. PubMed ID: 22037332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative exploration of healthcare relationships following delayed diagnosis of ovarian cancer and subsequent participation in supportive-expressive group therapy.
    Walker LM; Robinson JW
    Oncol Nurs Forum; 2009 Nov; 36(6):E310-6. PubMed ID: 19887344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.
    Zilliacus E; Meiser B; Gleeson M; Watts K; Tucker K; Lobb EA; Mitchell G
    Support Care Cancer; 2012 Nov; 20(11):2949-58. PubMed ID: 22441502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the moment: women speak about surgical treatment decision making days after a breast cancer diagnosis.
    Lally RM
    Oncol Nurs Forum; 2009 Sep; 36(5):E257-65. PubMed ID: 19726385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploration of the patient navigator role: perspectives of younger women with breast cancer.
    Pedersen AE; Hack TF; McClement SE; Taylor-Brown J
    Oncol Nurs Forum; 2014 Jan; 41(1):77-88. PubMed ID: 24368241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient perspectives on the usefulness of routine telephone follow-up as psychosocial support for hematologic malignancies: Australian findings.
    McGrath P
    Oncol Nurs Forum; 2014 Jan; 41(1):40-4. PubMed ID: 24368238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information needs, sources of information, and decisional roles in women with breast cancer.
    Bilodeau BA; Degner LF
    Oncol Nurs Forum; 1996 May; 23(4):691-6. PubMed ID: 8735327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
    Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
    Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumental relating and treatment decision making among older women with early-stage breast cancer.
    Pieters HC; Heilemann MV; Maliski S; Dornig K; Mentes J
    Oncol Nurs Forum; 2012 Jan; 39(1):E10-9. PubMed ID: 22201664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signs of aging or the vague symptoms of ovarian cancer?
    Smith A; Rocconi RP; Finan MA
    Oncol Nurs Forum; 2012 Mar; 39(2):E150-6. PubMed ID: 22374503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncology health professionals' attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer.
    Burcher S; Meiser B; Mitchell G; Saunders C; Rahman B; Tucker K; Barlow-Stewart K; Watts K; Gleeson M; Kirk J
    Per Med; 2013 Jul; 10(5):431-440. PubMed ID: 29758836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Cautiously optimistic that today will be another day with my disease under control": understanding women's lived experiences of ovarian cancer.
    Burles M; Holtslander L
    Cancer Nurs; 2013; 36(6):436-44. PubMed ID: 23348660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.
    Brain K; Gravell C; France E; Fiander A; Gray J
    Gynecol Oncol; 2004 Mar; 92(3):905-13. PubMed ID: 14984959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women with newly diagnosed breast cancer and their perceptions of needs in a health-care context.
    Landmark BT; Bøhler A; Loberg K; Wahl AK
    J Clin Nurs; 2008 Apr; 17(7B):192-200. PubMed ID: 18578795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.